ネクセラファーマの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2018/09/27 | 1,420 | 1,488 | 1,383 | 1,403 | +57 | +4.2% | 10,802,100 |
| 2018/09/26 | 1,225 | 1,430 | 1,210 | 1,346 | +157 | +13.2% | 15,332,800 |
| 2018/09/25 | 1,217 | 1,252 | 1,161 | 1,189 | -27 | -2.2% | 6,457,800 |
| 2018/09/21 | 1,034 | 1,234 | 1,030 | 1,216 | +92 | +8.2% | 22,421,100 |
| 2018/09/20 | 1,124 | 1,124 | 1,124 | 1,124 | -300 | -21.1% | 169,200 |
| 2018/09/19 | 1,424 | 1,424 | 1,424 | 1,424 | -400 | -21.9% | 139,500 |
| 2018/09/18 | 1,802 | 1,855 | 1,775 | 1,824 | +22 | +1.2% | 1,498,000 |
| 2018/09/14 | 1,779 | 1,810 | 1,748 | 1,802 | +38 | +2.2% | 1,762,400 |
| 2018/09/13 | 1,673 | 1,774 | 1,672 | 1,764 | +107 | +6.5% | 1,730,000 |
| 2018/09/12 | 1,704 | 1,740 | 1,650 | 1,657 | -57 | -3.3% | 1,136,000 |
| 2018/09/11 | 1,688 | 1,722 | 1,657 | 1,714 | +33 | +2% | 1,004,300 |
| 2018/09/10 | 1,682 | 1,734 | 1,675 | 1,681 | -19 | -1.1% | 756,000 |
| 2018/09/07 | 1,663 | 1,710 | 1,627 | 1,700 | +7 | +0.4% | 946,200 |
| 2018/09/06 | 1,715 | 1,725 | 1,640 | 1,693 | -45 | -2.6% | 1,597,700 |
| 2018/09/05 | 1,780 | 1,849 | 1,736 | 1,738 | -19 | -1.1% | 3,892,400 |
| 2018/09/04 | 1,656 | 1,818 | 1,653 | 1,757 | +116 | +7.1% | 4,098,100 |
| 2018/09/03 | 1,702 | 1,730 | 1,626 | 1,641 | -61 | -3.6% | 1,294,200 |
| 2018/08/31 | 1,633 | 1,720 | 1,621 | 1,702 | +43 | +2.6% | 1,352,200 |
| 2018/08/30 | 1,700 | 1,709 | 1,622 | 1,659 | -33 | -2% | 1,589,100 |
| 2018/08/29 | 1,674 | 1,710 | 1,633 | 1,692 | +7 | +0.4% | 1,521,200 |
| 2018/08/28 | 1,725 | 1,820 | 1,611 | 1,685 | -39 | -2.3% | 5,134,000 |
| 2018/08/27 | 1,543 | 1,730 | 1,532 | 1,724 | +185 | +12% | 3,467,300 |
| 2018/08/24 | 1,471 | 1,560 | 1,436 | 1,539 | +75 | +5.1% | 2,180,800 |
| 2018/08/23 | 1,424 | 1,527 | 1,421 | 1,464 | +51 | +3.6% | 2,480,600 |
| 2018/08/22 | 1,388 | 1,422 | 1,367 | 1,413 | +18 | +1.3% | 780,400 |
| 2018/08/21 | 1,300 | 1,403 | 1,300 | 1,395 | +85 | +6.5% | 1,329,400 |
| 2018/08/20 | 1,295 | 1,345 | 1,291 | 1,310 | +45 | +3.6% | 1,256,400 |
| 2018/08/17 | 1,244 | 1,274 | 1,236 | 1,265 | +51 | +4.2% | 861,900 |
| 2018/08/16 | 1,201 | 1,233 | 1,185 | 1,214 | -11 | -0.9% | 962,700 |
| 2018/08/15 | 1,246 | 1,264 | 1,205 | 1,225 | -12 | -1% | 1,006,700 |
| 2018/08/14 | 1,273 | 1,279 | 1,213 | 1,237 | -18 | -1.4% | 1,520,000 |
| 2018/08/13 | 1,350 | 1,355 | 1,250 | 1,255 | -114 | -8.3% | 2,099,600 |
| 2018/08/10 | 1,440 | 1,474 | 1,363 | 1,369 | ±0 | ±0% | 2,071,400 |
| 2018/08/09 | 1,366 | 1,385 | 1,358 | 1,369 | -2 | -0.1% | 401,000 |
| 2018/08/08 | 1,401 | 1,401 | 1,366 | 1,371 | -35 | -2.5% | 622,500 |
| 2018/08/07 | 1,380 | 1,421 | 1,371 | 1,406 | +25 | +1.8% | 923,100 |
| 2018/08/06 | 1,374 | 1,397 | 1,368 | 1,381 | +12 | +0.9% | 607,800 |
| 2018/08/03 | 1,374 | 1,406 | 1,367 | 1,369 | -5 | -0.4% | 764,800 |
| 2018/08/02 | 1,378 | 1,404 | 1,366 | 1,374 | -2 | -0.1% | 533,800 |
| 2018/08/01 | 1,396 | 1,411 | 1,376 | 1,376 | -20 | -1.4% | 563,300 |
| 2018/07/31 | 1,371 | 1,399 | 1,367 | 1,396 | +15 | +1.1% | 504,300 |
| 2018/07/30 | 1,422 | 1,437 | 1,377 | 1,381 | -41 | -2.9% | 799,500 |
| 2018/07/27 | 1,393 | 1,429 | 1,375 | 1,422 | +32 | +2.3% | 612,100 |
| 2018/07/26 | 1,408 | 1,432 | 1,371 | 1,390 | -26 | -1.8% | 1,067,700 |
| 2018/07/25 | 1,429 | 1,475 | 1,406 | 1,416 | -19 | -1.3% | 1,116,300 |
| 2018/07/24 | 1,355 | 1,475 | 1,355 | 1,435 | +104 | +7.8% | 3,203,400 |
| 2018/07/23 | 1,336 | 1,352 | 1,325 | 1,331 | +2 | +0.2% | 602,100 |
| 2018/07/20 | 1,336 | 1,369 | 1,308 | 1,329 | -20 | -1.5% | 1,310,200 |
| 2018/07/19 | 1,403 | 1,405 | 1,338 | 1,349 | -35 | -2.5% | 728,300 |
| 2018/07/18 | 1,376 | 1,397 | 1,365 | 1,384 | +8 | +0.6% | 812,300 |
1501～
1550
件表示中 / 4976件
類似銘柄と比較する
現在ご覧いただいている「ネクセラファーマ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ネクセラファーマ | 113,200円 | +197.7% | - | 0.00% | 46.26倍 | 1.48倍 |
|
創薬ベンチャー老舗。買収で成長。英国の創薬事業に日本が柱の後期治験・製造販売事業加わる |
| 持田薬 | 331,500円 | +3.0% | +27.5% | 2.41% | 20.99倍 | 0.91倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 224,400円 | +13.6% | +29.2% | 2.05% | 11.64倍 | 1.12倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
| 杏林製薬 | 149,900円 | +3.2% | +4.5% | 3.47% | 17.22倍 | 0.66倍 |
|
医薬中堅。柱のぜんそく薬、呼吸器アレルギー薬は下期に比重。消化器領域育成。後発品も |
| ＪＣＲファーマ | 72,400円 | -3.7% | -36.7% | 2.76% | 23.84倍 | 1.56倍 |
|
ヒト成長ホルモン製剤が主力、バイオ後続品も成長。希少疾病のバイオ新薬開発にも取り組む |
市場注目の銘柄
チャート関連のコラム
